PRGO N Stock Overview
Provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 4/6 |
Perrigo Company plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$686.00 |
| 52 Week High | US$852.80 |
| 52 Week Low | US$619.00 |
| Beta | 0.80 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -3.79% |
| 33 Year Change | -46.51% |
| 5 Year Change | n/a |
| Change since IPO | -39.01% |
Recent News & Updates
Recent updates
Shareholder Returns
| PRGO N | MX Pharmaceuticals | MX Market | |
|---|---|---|---|
| 7D | 0% | -3.0% | -2.6% |
| 1Y | -3.8% | -17.5% | -2.7% |
Return vs Industry: PRGO N exceeded the MX Pharmaceuticals industry which returned -15% over the past year.
Return vs Market: PRGO N underperformed the MX Market which returned 3.7% over the past year.
Price Volatility
| PRGO N volatility | |
|---|---|
| PRGO N Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 6.6% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in MX Market | 6.3% |
| 10% least volatile stocks in MX Market | 2.6% |
Stable Share Price: PRGO N has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PRGO N's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1887 | 8,900 | Murray Kessler | www.perrigo.com |
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in Ireland, the United States, France, Belgium, China, the United Kingdom, Germany, Switzerland, Austria, Italy, Australia, Greece, and Spain. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The Consumer Self-Care Americas segment develops, manufacture, and markets self-care products including upper respiratory, pain and sleep-aids, digestive health, nutrition, healthy lifestyle, skincare, women’s health, and other products, as well as vitamins, minerals and supplements, and oral self-care in the United States and Canada.
Perrigo Company plc Fundamentals Summary
| PRGO N fundamental statistics | |
|---|---|
| Market cap | Mex$89.42b |
| Earnings (TTM) | -Mex$2.36b |
| Revenue (TTM) | Mex$80.43b |
1.1x
P/S Ratio-37.8x
P/E RatioIs PRGO N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PRGO N income statement (TTM) | |
|---|---|
| Revenue | US$4.45b |
| Cost of Revenue | US$3.00b |
| Gross Profit | US$1.46b |
| Other Expenses | US$1.59b |
| Earnings | -US$130.90m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
May 09, 2023
| Earnings per share (EPS) | -0.97 |
| Gross Margin | 32.69% |
| Net Profit Margin | -2.94% |
| Debt/Equity Ratio | 84.4% |
How did PRGO N perform over the long term?
See historical performance and comparison